Benzinga | Nov 8, 2021 07:07AM EST

eFFECTOR Therapeutics Q3 EPS $0.42 Up From $(5.29) YoY, Sales $427.00K Down From $574.00K YoY

eFFECTOR Therapeutics (NASDAQ:EFTR) reported quarterly earnings of $0.42 per share. This is a 107.94 percent increase over losses of $(5.29) per share from the same period last year. The company reported $427.00 thousand in sales this quarter. This is a 25.61 percent decrease over sales of $574.00 thousand the same period last year.